These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Correlates of zinc finger BED domain-containing protein 3 and ghrelin in metabolic syndrome patients with and without prediabetes. AbuZayed R; Bulatova N; Kasabri V; Suyagh M; Halaseh L; AlAlawi S Horm Mol Biol Clin Investig; 2019 Jan; 37(3):. PubMed ID: 30667367 [TBL] [Abstract][Full Text] [Related]
4. Clinical and Liver Enzymes among the Patients with Metabolic Syndrome with or without Non Alcoholic Fatty Liver Disease attending a Tertiary Care Hospital. Mondal E; Karim MR; Begum A; Hassan K; Noor SM; Khan MM; Khan KH; Ashrafuzzaman SM Mymensingh Med J; 2023 Apr; 32(2):338-347. PubMed ID: 37002743 [TBL] [Abstract][Full Text] [Related]
5. Correlates of resistin and retinol-binding protein 4 in metabolic syndrome patients with and without prediabetes. Horan AA; Albsoul-Younes A; Kasabri V; Suyagh M; Halaseh L; AlAlawi S Horm Mol Biol Clin Investig; 2019 Jan; 37(3):. PubMed ID: 30667366 [TBL] [Abstract][Full Text] [Related]
6. Glucagon-Like Peptide-1 Receptor Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity/Metabolic Syndrome, Prediabetes/Diabetes and Non-Alcoholic Fatty Liver Disease-Current Evidence. Muzurović EM; Volčanšek Š; Tomšić KZ; Janež A; Mikhailidis DP; Rizzo M; Mantzoros CS J Cardiovasc Pharmacol Ther; 2022; 27():10742484221146371. PubMed ID: 36546652 [TBL] [Abstract][Full Text] [Related]
7. Serum lipidomics profiles reveal potential lipid markers for prediabetes and type 2 diabetes in patients from multiple communities. Xuan Q; Hu C; Zhang Y; Wang Q; Zhao X; Liu X; Wang C; Jia W; Xu G Front Endocrinol (Lausanne); 2022; 13():966823. PubMed ID: 36060983 [TBL] [Abstract][Full Text] [Related]
8. Sex differences in 10-year ischemic cardiovascular disease risk prediction in Chinese patients with prediabetes and type 2 diabetes. Yang L; Fish AF; Zhu Y; Yuan X; Li J; Wang X; Yuan L; Jia Z; Liu C; Xu Y; Lou Q BMC Cardiovasc Disord; 2019 Dec; 19(1):301. PubMed ID: 31881945 [TBL] [Abstract][Full Text] [Related]
9. Proportional correlates of cystatin-C with pentraxin-3, visceral adiposity index and atherogenicity index of plasma but not blood indices in metabolic syndrome patients with and without prediabetes. Al-Batsh MMW; Albsoul-Younes A; Kasabri V; Suyagh M; Alalawi S; Yasin N Horm Mol Biol Clin Investig; 2018 Nov; 36(3):. PubMed ID: 30496135 [TBL] [Abstract][Full Text] [Related]
10. Different Combinations of Glucose Tolerance and Blood Pressure Status and Incident Diabetes, Hypertension, and Chronic Kidney Disease. Derakhshan A; Bagherzadeh-Khiabani F; Arshi B; Ramezankhani A; Azizi F; Hadaegh F J Am Heart Assoc; 2016 Aug; 5(8):. PubMed ID: 27543801 [TBL] [Abstract][Full Text] [Related]
11. Unrecognized Prediabetes Is Highly Prevalent in Men With Erectile Dysfunction-Results From a Cross-Sectional Study. Boeri L; Capogrosso P; Pederzoli F; Ventimiglia E; Frego N; Chierigo F; Montanari E; Montorsi F; Salonia A J Sex Med; 2018 Aug; 15(8):1117-1124. PubMed ID: 30078463 [TBL] [Abstract][Full Text] [Related]
12. Non-alcoholic fatty liver disease predicts type 2 diabetes mellitus, but not prediabetes, in Xi'an, China: a five-year cohort study. Ming J; Xu S; Gao B; Liu G; Ji Y; Yang F; Jia Y; Fang Y; Ji Q Liver Int; 2015 Nov; 35(11):2401-7. PubMed ID: 25879672 [TBL] [Abstract][Full Text] [Related]
13. Risk factors differentially associated with non-alcoholic fatty liver disease in males and females with metabolic syndrome. Bullón Vela MV; Abete I; Zulet MLÁ; Tur JA; Pintó X; Corbella E; Martínez González MÁ; Corella D; Macías González M; Tinahones F; Fitó M; Estruch R; Ros E; Salas Salvadó J; Daimiel L; Martínez JA Rev Esp Enferm Dig; 2020 Feb; 112(2):94-100. PubMed ID: 31880161 [TBL] [Abstract][Full Text] [Related]
14. Association of Hepatic Steatosis Index and Fatty Liver Index with Carotid Atherosclerosis in Type 2 Diabetes. Wang C; Cai Z; Deng X; Li H; Zhao Z; Guo C; Zhang P; Li L; Gu T; Yang L; Zhao L; Wang D; Yuan G Int J Med Sci; 2021; 18(14):3280-3289. PubMed ID: 34400897 [No Abstract] [Full Text] [Related]
15. Use of a Metabolic Syndrome Severity DeBoer MD; Filipp SL; Gurka MJ Diabetes Care; 2018 Nov; 41(11):2421-2430. PubMed ID: 30275282 [TBL] [Abstract][Full Text] [Related]
16. Incidental Risk of Type 2 Diabetes Mellitus among Patients with Confirmed and Unconfirmed Prediabetes. Brunisholz KD; Joy EA; Hashibe M; Gren LH; Savitz LA; Hamilton S; Cannon W; Kim J PLoS One; 2016; 11(7):e0157729. PubMed ID: 27427913 [TBL] [Abstract][Full Text] [Related]
17. Impact of fatty liver disease and metabolic syndrome on incident type 2 diabetes; a population based cohort study. Mitsuhashi K; Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukuda T; Fukui M Endocr J; 2017 Nov; 64(11):1105-1114. PubMed ID: 28867686 [TBL] [Abstract][Full Text] [Related]
18. Comparison of noninvasive scoring systems for the prediction of nonalcoholic fatty liver disease in metabolic syndrome patients. Saokaew S; Kositamongkol C; Charatcharoenwitthaya P; Srivanichakorn W; Washirasaksiri C; Chaiyakunapruk N; Phisalprapa P Medicine (Baltimore); 2020 Dec; 99(50):e23619. PubMed ID: 33327335 [TBL] [Abstract][Full Text] [Related]
19. Gender Differences in the Relationships among Metabolic Syndrome and Various Obesity-Related Indices with Nonalcoholic Fatty Liver Disease in a Taiwanese Population. Lin IT; Lee MY; Wang CW; Wu DW; Chen SC Int J Environ Res Public Health; 2021 Jan; 18(3):. PubMed ID: 33498329 [TBL] [Abstract][Full Text] [Related]
20. Colonic Diverticulosis and Non-Alcoholic Fatty Liver Disease: Is There a Connection? Pantic I; Lugonja S; Rajovic N; Dumic I; Milovanovic T Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056346 [No Abstract] [Full Text] [Related] [Next] [New Search]